3.3 Chronic Lymphocytic Leukaemia Flashcards
Leukaemias are conditions characterised by a clonal increase in white blood cells in the peripheral blood or bone marrow
Typical illness presentation of CLL – usually affects elderly patients and is an incidental finding
- A 65 year old Chinese male presents with the problem of an incidental finding of ______________, he is otherwise asymptomatic
o Physical examination reveals _____________ and a small splenomegaly of 2 cm – CLL is usually diagnosed with the work-up of these enlarged lymph nodes
o Laboratory results – only abnormality is leukocytosis
leucocytosis and lymphocytosis;
small cervical lymph nodes
Morphology of cells in CLL – peripheral blood film
- ______________ – most abundant cells, fragile and many are damaged in the smearing process leading
appearance of ____________
- Lymphocytes with prominent nucleolus may be seen in some types of CLL
- ____________ – up to half of lymphocytes in CLL
Mature lymphocytes;
smear cells;
Prolymphocytes
Epidemiology of CLL
- Most common leukaemia in adults in the west, less common than _____________ in Singapore as a cause of lymphocytosis
o Ratio of male to female in TTSH is 1.2 (other reports 1.3 – 1.7)
o Median age at diagnosis in TTSH patients is 68 (range 32 – 93)
Natural history of CLL – an indolent B cell proliferation disorder
- Due to accumulation of malignant mature B lymphocytes over years
- Usually preceded by years of undiagnosed _________________
- Rate of accumulation varies – even upon diagnosis, many CLL patients show a slow accumulation of these malignant B cells that may accelerate in the later stages of disease
- As disease progresses, B cells accumulate in lymphoid tissues leading to lymphadenopathy and splenomegaly – can occasionally cause compressive symptoms
o Bone marrow failure – due to malignant B cell accumulation leading to __________________
o Transformation to high grade lymphoma (Richter’s) – may occur in later stages due to malignant B cells acquiring more mutations - Other complications may or may not be related to the stage of disease, although they are found more commonly in later stage diseases
o Autoimmune phenomenon – autoimmune haemolytic anaemia, autoimmune thrombocytopenia etc.
o Predilection for infections – bacterial infections such as _____________
splenic marginal zone lymphoma;
monoclonal B cell lymphocytosis (MBL);
progressive anemia and thrombocytopenia, reduction in normal white blood cells e.g. neutropenia;
Pneumococcal and Haemophilus;
Diagnosis
- A diagnosis of CLL can be made if the following criteria are satisfied
o Lymphocytosis > ____________
o Blood film shows small mature lymphocytes and smear cells
o Immunophenotype B cells, _______ positive, with a CLL score of 4-5
o Cytogenetics and molecular genetics
- Monoclonality of B cells are examined on flow cytometry
Normal: Mix of kappa and lambda light chain expressing B cells in ____________
CLL: Presence of a ______________ of lambda light chain-expressing B cells
Intensity of lambda B cell expression in malignant B cells is lower than normal B cells – Ig expression on cell surface will be weaker than normal
Immunophenotype of B cells in CLL – in this flow cytometry of all lymphocytes, CD19 and CD5 or CD23 are plotted
- Normal : CD19 is normally expressed on B cells (right of x-axis) and non-B cells (left of xaxis), _____ is usually expressed on T cells and a small population of B cells ______, a receptor for IgE, is expressed heterogeneously in B cells
- CLL: B cells all expresses CD5 and CD23
The more the clonal B cells expresses such features, the more confident the diagnosis of CLL
5 x 109/L;
CD5;
3:2 ratio;
monoclonal population;
CD5;
CD23
Prognosis and staging of CLL – Rai and Binet staging
- Rai staging – lower stages show lymphocytosis without _____________ and higher stages show _____________
o Median duration of survival for a low Rai and high Rai stage are at least 10 years and 1.5 years respectively
- CD38 on cell surface can be easily analysed on a flow cytometer – higher expression shows a worse prognosis
- Accompanying cytogenic features can also change
prognosis and treatment
o CLL patients harbouring a _______________ have a median survival of only 3 years after combining all stages of disease
o A __________________ relates to a median survival of more than 10 years
o Cytogenic profile is found to be an a stronger prognostic marker than stage of disease and is independent of each other
- Immunoglobulin gene mutation status – more frequently used prognostic marker
o Patients with cells that have not undergone __________________ (reprogramming) has a worse prognosis than patients which cells have been somatically hypermutated
lymphadenopathies;
anaemia and/or thrombocytopenia;
deletion in the short arm of chromosome 17;
deletion in the long arm of chromosome 13;
somatic hypermutation at the germinal centre
Treatment of CLL – not every patient requires treatment
- Routine practice not to treat CLL patients with a low risk
- A high staging (disease burden), symptomatic lymphadenopathy or splenomegaly is indicative of treatment
- Older strategy – chemotherapy and monoclonal antibodies (usually against ________________)
- Recently, targeted therapy is more in use – BKT is an important signalling molecule in CLL cell survival
o Inhibition of BKT is effective in controlling CLL, now a first line option for significant groups of CLL patients
o Other molecules known to play a role in CLL pathogenesis is__________________ – inhibitors of these pathways have been developed, currently in use for patients whose disease have relapsed after use of BKT inhibitors
Prophylaxis
- IV immunoglobulin is recommended for those with ________________ and recurrent bacterial infections – these patients are prone to infections
- Immunisation against _________________
CD20 on B cells;
PI3K and the BCL2 anti-apoptotic pathway;
hypo-gammaglobulinemia;
Pneumococcus, Haemophilus and seasonal influenza